ArticleDiscover oncology2025
Single-cell RNA-seq reveals gene expression heterogeneity in NSCLC and its link to the immune microenvironment.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
backgroundNon-small cell lung cancer (NSCLC) is one of the leading cause of cancer-associated mortality globally. Its tumor microenvironment consists of various types of cells, which have a great impact on patient response and prognosis. The present study used scRNA-seq technology to investigate gene expression pattern of various cell types in NSCLC and their correlation with immune microenvironment.
methodsWe acquired NSCLC single-cell RNA sequencing data from GSE117570 and employed UMAP clustering analysis to explore the major cell subpopulations. Additionally, we explored the differential expression of important genes among various cell types and their associations with immune cell infiltration, scores of tumor microenvironment.
resultsOur results exhibited the heterogenicity of cell types in NSCLC and also indicated more than 60 genes whose expression displayed significant differences between cell groups, such as AP1S1, BTK, FUCA1, NDEL14, TMEM106B and UNC13D. Expression of these genes correlated with immunocyte infiltration, tumor microenvironment scores, indicating their potential roles in tumor progression and therapeutics.
conclusionOur single-cell transcriptomic dissection of NSCLC highlights cellular heterogeneity as well as potential biomarkers associated with immune microenvironment. The findings provide a foundation for the rational development of biomarker-driven personalized treatment and therapy by extending the cell-type specificity of current designs of NSCLC therapeutics.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.